Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 104 of 104 entries
View as:
Phase: N/A
Priority: Normal
Start: 04/17/23
End: 06/24/24
Due: 06/24/25
Phase: N/A
Priority: Normal
Start: 12/31/15
End: 10/31/18
Due: 10/31/19
Phase: N/A
Priority: Normal
Start: 01/09/20
End: 01/04/23
Due: 01/04/24
Phase: N/A
Priority: Normal
Start: 09/30/22
End: 11/15/24
Due: 11/15/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Study of mRNA-1010 Seasonal Influenza Vaccine in Adults | NCT05827978 | ModernaTX, Inc. | user2@example.com | None | 2023-04-17 | 2024-06-24 | 2025-06-24 | - | - | 2025-07-14 |
| Safety, Tolerability, and Immunogenicity of VAL-506440 in Healthy Adult Subjects | NCT03076385 | ModernaTX, Inc. | user2@example.com | None | 2015-12-31 | 2018-10-31 | 2019-10-31 | - | - | 2025-07-14 |
| Dose-Finding Trial to Evaluate the Safety and Immunogenicity of Cytomegalovirus (CMV) Vaccine mRNA-1647 in Healthy Adults | NCT04232280 | ModernaTX, Inc. | user2@example.com | None | 2020-01-09 | 2023-01-04 | 2024-01-04 | - | - | 2025-07-14 |
| Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273.214 SARS-CoV-2 (COVID-19) Vaccine in Infants | NCT05584202 | ModernaTX, Inc. | user2@example.com | None | 2022-09-30 | 2024-11-15 | 2025-11-15 | - | - | 2025-07-14 |